发生严重肝脏事件后,Intellia暂停基因编辑疗法的后期试验

路透中文
Oct 27, 2025
发生严重肝脏事件后,<a href="https://laohu8.com/S/NTLA">Intellia</a>暂停基因编辑疗法的后期试验

路透10月27日 - Intellia Therapeutics NTLA.O周一表示,由于一名患者出现了严重的肝脏问题,该公司已暂时停止了其一次性基因编辑疗法治疗心脏病的两项后期研究的给药和患者筛查工作。

(为便利非英文母语者,路透将其报导自动化翻译为数种其他语言。由于自动化翻译可能有误,或未能包含所需语境,路透不保证自动化翻译文本的准确性,仅是为了便利读者而提供自动化翻译。对于因为使用自动化翻译功能而造成的任何损害或损失,路透不承担任何责任。)

At the request of the copyright holder, you need to log in to view this content

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10